文献速递呼吸危重症与机械通气

新生儿ARDS的Montreux定义:新疾病实体的生物学与临床背景

The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity.
PubMed 文献 · Lancet Respir Med · 2017-07-04

新生儿急性呼吸窘迫综合征(ARDS)此前缺乏定义,本项目通过国际多学科专家共识制定了适用于围产期的新生儿ARDS定义(Montreux定义),并指出导致成人及年长儿ARDS的机制(表面活性物质功能障碍、肺组织炎症、肺容积减少、分流增加、弥漫性肺泡损伤)也存在于多种新生儿危重呼吸疾病中。

要点

  • Montreux定义为首个新生儿ARDS共识定义,适用于围产期。
  • 成人ARDS的核心机制同样见于新生儿危重呼吸疾病。
  • 该定义由欧美多学会专家协作制定,具国际代表性。

核心结论

  • 新生儿ARDS此前无定义,Montreux定义为首个适用于围产期的共识定义。
  • 专家共识认为成人及年长儿ARDS的机制也存在于多种新生儿危重呼吸疾病中。

研究设计与样本

  • 国际性、协作性、多中心、多学科项目(Neonatal ARDS Project)。
  • 定义由欧洲儿科与新生儿重症监护学会5名专家、欧洲儿科研究学会4名专家、美国2名独立专家及澳大利亚2名独立专家讨论产生。

主要发现

  • 专家共识指出复杂表面活性物质功能障碍、肺组织炎症、肺容积减少、分流增加和弥漫性肺泡损伤在多种新生儿危重呼吸疾病中存在。

关键数值与推荐

  • Montreux定义为新生儿ARDS的共识定义,适用于围产期。

临床怎么用

  • 为新生儿ARDS提供统一共识定义,便于临床识别与围产期应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute respiratory distress syndrome (ARDS) is undefined in neonates, despite the long-standing existing formal recognition of ARDS syndrome in later life. We describe the Neonatal ARDS Project: an international, collaborative, multicentre, and multidisciplinary project which aimed to produce an ARDS consensus definition for neonates that is applicable from the perinatal period. The definition was created through discussions between five expert members of the European Society for Paediatric and Neonatal Intensive Care; four experts of the European Society for Paediatric Research; two independent experts from the USA and two from Australia. This Position Paper provides the first consensus definition for neonatal ARDS (called the Montreux definition). We also provide expert consensus that mechanisms causing ARDS in adults and older children-namely complex surfactant dysfunction, lung tissue inflammation, loss of lung volume, increased shunt, and diffuse alveolar damage-are also present in several critical neonatal respiratory disorders.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med. 2017. PMID: 28687343. doi:10.1016/S2213-2600(17)30214-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。